Radioiodine Refractory Differentiated Thyroid Cancer clinical trials

Explore recruiting radioiodine refractory differentiated thyroid cancer clinical trials.

Recruiting radioiodine refractory differentiated thyroid cancer studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Radioiodine Refractory Differentiated Thyroid Cancer trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study of Cabozantinib (XL184) in Subjects with Radioiodine-Refractory Differentiated Thyroid Cancer Who Have Progressed after Prior VEGFR-Targeted Therapy

Romania, Poland, Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

REGOMUNE : A phase I/II study of Regorafenib plus Avelumab in solid tumors

France

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Radioiodine Refractory Differentiated Thyroid Cancer trials by city

Radioiodine Refractory Differentiated Thyroid Cancer in Toronto Radioiodine Refractory Differentiated Thyroid Cancer in Vancouver Radioiodine Refractory Differentiated Thyroid Cancer in Montreal Radioiodine Refractory Differentiated Thyroid Cancer in Calgary Radioiodine Refractory Differentiated Thyroid Cancer in Edmonton Radioiodine Refractory Differentiated Thyroid Cancer in Ottawa Radioiodine Refractory Differentiated Thyroid Cancer in Winnipeg Radioiodine Refractory Differentiated Thyroid Cancer in Quebec City Radioiodine Refractory Differentiated Thyroid Cancer in Hamilton Radioiodine Refractory Differentiated Thyroid Cancer in Kitchener Radioiodine Refractory Differentiated Thyroid Cancer in London Radioiodine Refractory Differentiated Thyroid Cancer in Halifax Radioiodine Refractory Differentiated Thyroid Cancer in New York Radioiodine Refractory Differentiated Thyroid Cancer in Los Angeles Radioiodine Refractory Differentiated Thyroid Cancer in Chicago Radioiodine Refractory Differentiated Thyroid Cancer in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease